Stellate Ganglion Block for the Treatment of Post-Traumatic Stress Disorder, Depression, and Anxiety


 The evidence regarding the clinical effectiveness of stellate ganglion block for treatment post-traumatic stress disorder was mixed. A randomized controlled trial included in a systematic review did not detect significant differences symptoms versus sham groups, while another significantly greater improvements between these groups. Furthermore, second detected depression, anxiety, and distress, but pain mental physical functioning participants receiving compared to sham.
 Authors rates adverse events Of 6 reported trial, 3 were deemed related (injection site pain, self-resolving bradycardia, temporary laryngeal irritation); statistical analysis reported.
 1 evidence-based guideline unable provide recommendations or against use because insufficient evidence.
 No relevant literature guidelines depression anxiety identified.